← Latest Filings
A

ARCH Venture Partners XII, LLC

Open-market buys
3
$27.9M total
Open-market sells
0
$0 total
Tracking since
Oct 2025
Open-market buy — $3.1M
CITY THERAPEUTICS, INC. · Oct 19, 2026
Open-market buy — $19.8M
Open-market trades from the last two years.
13,692,507 Common Stock in CTY
Held indirectly (By ARCH Venture Fund XII, L.P.) · as of 2026-10-19
12,205,379 Common Stock in NMRA
Held indirectly (By ARCH Venture Fund X, L.P.) · as of 2025-10-27
CITY THERAPEUTICS, INC.
CIK 0002143850
Neumora Therapeutics, Inc.
CIK 0001885522